Antibiotics Flashcards
Penicillin G
Narrow Spectrum Penicillin Compound
(Cell Wall Synthesis Inhibitor)
MOA: inhibit Penicillin Binding Proteins
Adverse: Hypersensitivity
Penicillin V
Narrow Spectrum Penicillin Compound
(Cell Wall Synthesis Inhibitor)
MOA: inhibit Penicillin Binding Proteins
Adverse: Hypersensitivity
Amoxicillin
Penicillin Compound
(Cell Wall Synthesis Inhibitor)
MOA: inhibit Penicillin Binding Proteins
Adverse: Hypersensitivity
Methicillin
Narrow Spectrum Penicillin Compound
(Cell Wall Synthesis Inhibitor)
MOA: inhibit Penicillin Binding Proteins
Adverse: Hypersensitivity
B-lactamase resistant
Nafcillin
Narrow Spectrum Penicillin Compound
(Cell Wall Synthesis Inhibitor)
MOA: inhibit Penicillin Binding Proteins
Adverse: Hypersensitivity
B-lactamase resistant
Oxacillin
Narrow Spectrum Penicillin Compound
(Cell Wall Synthesis Inhibitor)
MOA: inhibit Penicillin Binding Proteins
Adverse: Hypersensitivity
B-lactamase resistant
Ampicillin
Penicillin Compound
(Cell Wall Synthesis Inhibitor)
MOA: inhibit Penicillin Binding Proteins
Adverse: Hypersensitivity
Piperacillin
Penicillin Compound
(Cell Wall Synthesis Inhibitor)
MOA: inhibit Penicillin Binding Proteins
Adverse: Hypersensitivity
Ticarcillin
Penicillin Compound
(Cell Wall Synthesis Inhibitor)
MOA: inhibit Penicillin Binding Proteins
Adverse: Hypersensitivity
Azlocillin
Penicillin Compound
(Cell Wall Synthesis Inhibitor)
MOA: inhibit Penicillin Binding Proteins
Adverse: Hypersensitivity
Clavulanic acid
B-lactamase inhibitor
MOA: inhibit B-lactamase
Used in combination w/ penicillin agent
Cefazolin
1st Generation Cephalosporin
(Cell Wall Synthesis Inhibitor)
MOA: inhibit Penicillin Binding Protein
Adverse: Hypersensitivity
Cephalexin
1st Generation Cephalosporin
(Cell Wall Synthesis Inhibitor)
MOA: inhibit Penicillin Binding Protein
Adverse: Hypersensitivity
Cefotetan
2nd Generation Cephalosporin
(Cell Wall Synthesis Inhibitor)
MOA: inhibit Penicillin Binding Protein
Adverse: Hypersensitivity
Cefaclor
2nd Generation Cephalosporin
(Cell Wall Synthesis Inhibitor)
MOA: inhibit Penicillin Binding Protein
Adverse: Hypersensitivity
Cefuroxime
2nd Generation Cephalosporin
(Cell Wall Synthesis Inhibitor)
MOA: inhibit Penicillin Binding Protein
Adverse: Hypersensitivity
Ceftriaxone
3rd Generation Cephalosporin
(Cell Wall Synthesis Inhibitor)
MOA: inhibit Penicillin Binding Protein
Adverse: Hypersensitivity
can enter CNS
Cefotaxime
3rd Generation Cephalosporin
(Cell Wall Synthesis Inhibitor)
MOA: inhibit Penicillin Binding Protein
Adverse: Hypersensitivity
can enter CNS
Cefdinir
3rd Generation Cephalosporin
(Cell Wall Synthesis Inhibitor)
MOA: inhibit Penicillin Binding Protein
Adverse: Hypersensitivity
can enter CNS
Cefixime
3rd Generation Cephalosporin
(Cell Wall Synthesis Inhibitor)
MOA: inhibit Penicillin Binding Protein
Adverse: Hypersensitivity
can enter CNS
Cefepime
4th Generation Cephalosporin
(Cell Wall Synthesis Inhibitor)
MOA: inhibit Penicillin Binding Protein
Adverse: Hypersensitivity
can enter CNS
Rx to treat MRSA
Vancomycin, Linezolid, Daptomycin
Aztreonam
Monobactam
(Cell Wall Synthesis Inhibitor)
MOA: inhibit Penicillin Binding Protein
Rx: CNS or severe infections
(Gram (-) ONLY)
Adverse: Hypersensitivity
can enter CNS
Doripenem
Carbapenem
MOA: inhibit Penicillin Binding Protein
(Cell Wall Synthesis Inhibitor)
Adverse: N/V/diarrhea
Ertapenem
Carbapenem
MOA: inhibit Penicillin Binding Protein
(Cell Wall Synthesis Inhibitor)
Adverse: N/V/diarrhea
Meropenem
Carbapenem
MOA: inhibit Penicillin Binding Protein
(Cell Wall Synthesis Inhibitor)
Adverse: N/V/diarrhea
Imipenem
Carbapenem
MOA: inhibit Penicillin Binding Protein
(Cell Wall Synthesis Inhibitor)
Adverse: N/V/diarrhea
Must combine w/ cilastatin to prevent inactivation in kidney
Vancomycin
Glycopeptide
MOA: steric inhibitor prevents elongation of peptidoglycan cell wall structure
Rx: MRSA, Enterococci, C. diff.
Adverse: skin flushing
Bacitracin
Polypeptides
MOA: blocks incorporation of amino acids / nucleic acids into cell wall
Rx: topical use
Fosfomycin
Phosphoenolypyruvate
MOA: inhibition of synthesis of disaccharide molecule
Rx: UTIs
Erythromycin
Macrolide
(Protein Synthesis Inhibitor)
MOA: Binds to 50S and impairs translocation to P site
Rx: ambulatory pneumonia, hospitalization penumonia (in combo w/ B-lactam)
Adverse: N/V/diarrhea
Clarithromycin
Macrolide
(Protein Synthesis Inhibitor)
MOA: Binds to 50S and impairs translocation to P site
Rx: ambulatory pneumonia, hospitalization penumonia (in combo w/ B-lactam)
Adverse: N/V/diarrhea
Azithromycin
Macrolide
(Protein Synthesis Inhibitor)
MOA: Binds to 50S and impairs translocation to P site
Rx: ambulatory pneumonia, hospitalization penumonia (in combo w/ B-lactam)
Adverse: N/V/diarrhea
Tetracycline
Tetracycline
(Protein synthesis inhibitor)
MOA: binds to 30S, prevents binding of new tRNA to A site
Rx: Broad-spectrum –> bacteriostatic
SE: binds Ca, disrupts flora, photosensitivity
Minocycline
Tetracycline
(Protein synthesis inhibitor)
MOA: binds to 30S, prevents binding of new tRNA to A site
Rx: Broad-spectrum –> bacteriostatic
SE: binds Ca, disrupts flora, photosensitivity
Tigercycline
Tetracycline
(Protein synthesis inhibitor)
MOA: binds to 30S, prevents binding of new tRNA to A site
Rx: Broad-spectrum –> bacteriostatic
SE: binds Ca, disrupts flora, photosensitivity
Doxycycline
Tetracycline
(Protein synthesis inhibitor)
MOA: binds to 30S, prevents binding of new tRNA to A site
Rx: Broad-spectrum –> bacteriostatic
SE: binds Ca, disrupts flora, photosensitivity
Clindamycin
Protein Synthesis Inhibitor
MOA: binds to 50S, prevents formation of initiation complex and translocation to P site
Rx: ST infections, MRSA
SE: GI, dev. of C. diff.
Chloramphenicol
Protein Synthesis Inhibitor
MOA: binds to 50S, prevents peptide bond formation
Rx: serious infections, eye infections
SE: ↓ RBC production, Gray Baby Syndrome
Linezolid
Oxazolidinone
(Protein Synthesis Inhibitor)
MOA: binds to P site of 50S and targets first tRNA
Rx: Gram (+), resistant strains
SE: myelosuppression
Sulfadiazine
Sulfonamide
(antifolate)
MOA: compete w/ PABA for dihydropteroate synthase and block dihydrofolic acid synthesis
Rx: UTI
SE: Steven-Johnson syndrome
Sulfamethonazole
Sulfonamide
(antifolate)
MOA: compete w/ PABA for dihydropteroate synthase and block dihydrofolic acid synthesis
Rx: UTI
SE: Steven-Johnson syndrome
Sulfamethizole
Sulfonamide
(antifolate)
MOA: compete w/ PABA for dihydropteroate synthase and block dihydrofolic acid synthesis
Rx: UTI
SE: Steven-Johnson syndrome
Trimethoprim
Trimethoprim
(Antifolate)
MOA: inhibits bacterial dihydrofolate reductase
Rx: UTIs
SE: BM suppression
Pyrimethamine
Trimethoprim
(Antifolate)
MOA: inhibits bacterial dihydrofolate reductase
Rx: UTIs
SE: BM suppression
Trimethoprim-sulfamethoxazole (TMP-SMX)
Antifolate
MOA: synergistic activity when combing the two drugs
Rx: UTIs and prostatitis
SE: those seen w/ each agent alone
(BM suppression / Steven-Johnson Syndrome)
Ciprofloxacin
Fluoroquinolone (DNA synthesis inhibitor)
MOA: inhibit topoisomerase II and IV (prevent winding and separation of DNA)
Rx: UTI, STI, respiratory, anthrax
SE: N/V/D, bind divalent cations, QT prolongation
Levofloxacin
Fluoroquinolone (DNA synthesis inhibitor)
MOA: inhibit topoisomerase II and IV (prevent winding and separation of DNA)
Rx: UTI, STI, respiratory, anthrax
SE: N/V/D, bind divalent cations, QT prolongation
Norfloxacin
Least active
Fluoroquinolone (DNA synthesis inhibitor)
MOA: inhibit topoisomerase II and IV (prevent winding and separation of DNA)
Rx: UTI, STI, respiratory, anthrax
SE: N/V/D, bind divalent cations, QT prolongation
Ofloxacin
Fluoroquinolone (DNA synthesis inhibitor)
MOA: inhibit topoisomerase II and IV (prevent winding and separation of DNA)
Rx: UTI, STI, respiratory, anthrax
SE: N/V/D, bind divalent cations, QT prolongation
Gatifloxacin
Fluoroquinolone (DNA synthesis inhibitor)
MOA: inhibit topoisomerase II and IV (prevent winding and separation of DNA)
Rx: UTI, STI, respiratory, anthrax
SE: N/V/D, bind divalent cations, QT prolongation
Gemifloxacin
Fluoroquinolone (DNA synthesis inhibitor)
MOA: inhibit topoisomerase II and IV (prevent winding and separation of DNA)
Rx: UTI, STI, respiratory, anthrax
SE: N/V/D, bind divalent cations, QT prolongation
Moxifloxacin
Fluoroquinolone (DNA synthesis inhibitor)
MOA: inhibit topoisomerase II and IV (prevent winding and separation of DNA)
Rx: UTI, STI, respiratory, anthrax
SE: N/V/D, bind divalent cations, QT prolongation
Metronidazole
DNA damage
MOA: prodrug; undergoes chemical reduction in organism, binds to DNA, causes damage
Rx: anaerobic bacteria, protozoa
SE: N/V/D, disulfiram-effect (avoid alcohol)
Daptomycin
Lipopeptide (targets cell membrane)
MOA: causes depolarization of membrane
Rx: Gram (+), MRSA
SE: musculoskeletal system
Polymyxin B
Detergent
(targets cell membrane)
MOA: binds to phospholipid and disrups cell membrane (LPS)
Rx: Gram (-) bacteria
Streptomycin
Aminoglycoside
(Protein synthesis inhibitor)
MOA: Bind to 30S, blocks formation of initiation complex
Rx: serious Gram (-) infections (in combo w/ B-lactams)
SE: nephrotoxicity, ototoxicity
Gentamicin
Aminoglycoside
(Protein synthesis inhibitor)
MOA: Bind to 30S, blocks formation of initiation complex
Rx: serious Gram (-) infections (in combo w/ B-lactams)
SE: nephrotoxicity, ototoxicity
Kanamycin
Aminoglycoside
(Protein synthesis inhibitor)
MOA: Bind to 30S, blocks formation of initiation complex
Rx: serious Gram (-) infections (in combo w/ B-lactams)
SE: nephrotoxicity, ototoxicity
Amikacin
Aminoglycoside
(Protein synthesis inhibitor)
MOA: Bind to 30S, blocks formation of initiation complex
Rx: serious Gram (-) infections (in combo w/ B-lactams)
SE: nephrotoxicity, ototoxicity
Tobramycin
Aminoglycoside
(Protein synthesis inhibitor)
MOA: Bind to 30S, blocks formation of initiation complex
Rx: serious Gram (-) infections (in combo w/ B-lactams)
SE: nephrotoxicity, ototoxicity
Neomycin
Aminoglycoside
(Protein synthesis inhibitor)
MOA: Bind to 30S, blocks formation of initiation complex
Rx: serious Gram (-) infections (in combo w/ B-lactams)
SE: nephrotoxicity, ototoxicity
Nosocomial Superbugs
Enterococcus faeicium Staphylococcus aureus Klebsiella pneumoniae Acinetobcter baumanni Pseudomonas aeruginosa Enterobacter species
Daptomycin Resistance
Increased positive charge of cell membrane repels antibiotic
Tetracycline Resistance
Efflux pump is expessed on cytoplasmic membrane
Metronidazole Resistance
Mutation in reducing enzymes cause impaired activation of prodrug
Aminoglycoside Resistance
Phosphorylation, adenylation, and acetylation of the aminoglycoside can alter target binding (bacterial ribosome)
Amoxicillin Resistance
Beta-lactamase can hydrolyze the lactam ring and render it ineffective
Trimethoprim / Sulfonamide Resistance
Drug-insensitive enzymes dihydropteroate synthase and dihydrofolate reductase
Vancomycin Resistance
Substitution on the peptidoglycan stem so that agent can no longer bind to target (build wall without D-alanine)